MVV Stock UPDATES Ultra Midcap 400 Proshares (MVV) 71.50 09/17/2014

New Post Public Reply Private Reply Replies (0) Message Board

Sep 17, 2014 at 9:53 AM

Ultra Midcap 400 Proshares (MVV) 71.50 $MVV

Watch for ProShares Ultra MidCap400 to Potentially Pullback After Gaining 1.49% Yesterday
Comtex SmarTrend(R) - Tue Jul 01, 4:30PM CDT
ProShares Ultra MidCap400 (AMEX:MVV) traded in a range yesterday that spanned from a low of $72.30 to a high of $73.81. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high of $71.96 on volume of 8.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

ProShares Ultra MidCap400 Rises 1.49% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Tue Jul 01, 4:30PM CDT
ProShares Ultra MidCap400 (AMEX:MVV) traded in a range yesterday that spanned from a low of $72.30 to a high of $73.81. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high of $71.96 on volume of 8.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Direxion Files for Volatility Response and Leveraged ETFs - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Thu Jun 12, 7:00AM CDT
Direxion is looking to put out funds that focus on volatility, growth with a 1.25x metric, and mid caps.

After Yesterday's Decline of 7.52%, ProShares Ultra MidCap400 Offers Investors Better Value
Comtex SmarTrend(R) - Mon Feb 03, 4:37PM CST
ProShares Ultra MidCap400 (AMEX:MVV) traded in a range yesterday that spanned from a low of $55.90 to a high of $60.60. Yesterday, the shares fell 7.5%, which took the trading range below the 3-day low of $59.29 on volume of 11.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

ProShares Ultra MidCap400 Falls 7.52% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Mon Feb 03, 4:37PM CST
ProShares Ultra MidCap400 (AMEX:MVV) traded in a range yesterday that spanned from a low of $55.90 to a high of $60.60. Yesterday, the shares fell 7.5%, which took the trading range below the 3-day low of $59.29 on volume of 11.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

ProShares Ultra MidCap400 Up 21.0% Since SmarTrend Uptrend Call (MVV)
Comtex SmarTrend(R) - Tue Jan 21, 11:22AM CST
SmarTrend identified an Uptrend for ProShares Ultra MidCap400 (AMEX:MVV) on September 10th, 2013 at $105.70. In approximately 4 months, ProShares Ultra MidCap400 has returned 20.97% as of today's recent price of $127.87.

ProShares Ultra MidCap400 Has Returned 20.7% Since SmarTrend Recommendation (MVV)
Comtex SmarTrend(R) - Mon Jan 13, 9:27AM CST
SmarTrend identified an Uptrend for ProShares Ultra MidCap400 (AMEX:MVV) on September 10th, 2013 at $105.70. In approximately 4 months, ProShares Ultra MidCap400 has returned 20.74% as of today's recent price of $127.62.

18.6% Return Seen to Date on SmarTrend ProShares Ultra MidCap400 Call (MVV)
Comtex SmarTrend(R) - Fri Jan 03, 4:55PM CST
SmarTrend identified an Uptrend for ProShares Ultra MidCap400 (AMEX:MVV) on September 10th, 2013 at $105.70. In approximately 4 months, ProShares Ultra MidCap400 has returned 18.65% as of today's recent price of $125.41.

European ETFs: A Surge in Popularity? - ETF News And Commentary
Eric Dutram - ZACKS - Wed Sep 04, 9:01AM CDT
Four European ETFs (and two mid cap ETFs) are leading the way for inflows.

Time to Bet on Mid Cap ETFs? - ETF News And Commentary
Zacks Equity Research - ZACKS - Thu Aug 22, 7:00AM CDT
Investors have been piling into mid cap ETFs. Is it time for you to buy into the space too?

PKB, SLTM, PWE, MVV, TTM, PAL Are Seasonally Ripe To Go Down In the Next Five Weeks
M2 - Fri May 24, 4:28AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of POWERSHARES DYNAMIC BLDG & CONSTR PORT (NYSE

KB), Solta Medical Inc (NASDAQ:SLTM), Powertech Uranium Corp (NYSE

WE), ProShares Ultra MidCap400 (NYSE:MVV), Tata Motors Ltd (NYSE:TTM), NORTH AMER PALLADIUM LTD (AMEX

AL) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:

SSO, MVV, DDM, SWHC, AYR, DVR Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Fri Mar 29, 7:33AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Silver Standard Resources Inc (NYSE:SSO), ProShares Ultra MidCap400 (NYSE:MVV), ProShares Ultra Dow30 (NYSE

DM), SMITH & WESSON HOLDING CORPORATION (NASDAQ:SWHC), Aircastle Ltd (NYSE:AYR), Cal Dive International Inc (NYSE

VR) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:

KRE, MVV, HALO, DVR, BCPC, MELI Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Fri Mar 01, 6:03AM CST
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of SPDR S&P Regional Banking ETF (NYSE:KRE), ProShares Ultra MidCap400 (NYSE:MVV), Halozyme Therapeutics Inc (NASDAQ:HALO), Cal Dive International Inc (NYSE

VR), Balchem Corp (NASDAQ:BCPC), MercadoLibre Inc (NASDAQ:MELI) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:

Uptrend Call Working As ProShares Ultra MidCap400 Stock Rises 25.6% (MVV)
Comtex SmarTrend(R) - Wed Feb 20, 4:56PM CST
SmarTrend identified an Uptrend for ProShares Ultra MidCap400 (AMEX:MVV) on November 23rd, 2012 at $69.16. In approximately 3 months, ProShares Ultra MidCap400 has returned 25.56% as of today's recent price of $86.83.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innovent's SINTBILO® Hits Primary Endpoint in Study

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

TCL Tablets Arrive on BestBuy.com: What It Means

Go Big or Go Home: TCL's Bold Move TCL just dropped a little bombshell that's gonna ripple through the electronics retail market—its tablets and smartphones are now bright and shiny on BestBuy.com. It's like standing at the craps table and before you know it, the stakes have just doubled. Why? Best Buy ain't some hole-in-the-wall spot. It's the premium electronics...

ASTS Faces Class Action; Investors Beware of Pitfalls

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Formation Unveils First Solana Tokenized Securities Venue

Well, here we go. Formation Securities is setting sail on the high seas of blockchain, aiming to operate a tokenized securities venue (TSV) on Solana. This isn't your garden-variety launch—it's a bold leap into a newer, faster-paced world of trading. Sure, you’ve heard about blockchains before, but this operation marries the traditional rigmarole of the stock market...

Continuous Insulation Market Grows, Hits $67.74B by 2031

Market Trends and Key Drivers Imagine riding a slow but steady bull market in insulation—sounds mundane, but the numbers don't lie. MarketsandMarkets™ had the scoop, predicting the Continuous Insulation Market will balloon from USD 56.98 billion in 2026 to USD 67.74 billion by 2031, putting down roots with a 3.5% CAGR. Now, you and I both know that when real estate...

Tigo Energy Faces Class Action: Investor Deadline Looms

Unpacking Tigo's Rollercoaster: Lawsuit & Market Reaction They sometimes say, "When it rains, it pours." For Tigo Energy, it’s been more a downpour than a drizzle. Here we are, chasing down what's going on with Tigo Energy (NASDAQ:TYGO), fresh off the heels of a class action fuss that's grabbed every investor's attention. If you've got a stake, or even a passing...

O-I Glass Faces Class Action: Investor Implications

O-I Glass in Hot Water Over Misleading Statements I'll tell you, nothing gets my goat quite like uncovering deceptive practices in the corporate world. It seems O-I Glass, Inc. (NYSE: OI), might have played a fast one with its shareholders. The company is staring down the barrel of a class action lawsuit from Schall, Brown & Schwartz LLP, alleging they weren't entirely...

Photocure Navigates AssureMDx's Medicare Journey

Aiming High with AssureMDx Photocure's got this bladder cancer test called AssureMDx that's at the center of its recent moves after acquiring Vesica Health a few months back. This isn't just any test; it's a urine-based, non-invasive way to snag an early look at bladder cancer. With the FDA's Breakthrough Device tag pinned on, they're not just dipping their toes in—this...

AWS Boosts Agilix's AI Education in Sierra Leone

Agilix Labs' Landmark Leap with AWS Just when you think you've got the grip on global education dynamics, a new wave hits your shores, this time courtesy of Agilix Labs and AWS. Agilix Labs snagged a grant from Amazon Web Services, carving a path that blends AI with educational equity in Sierra Leone. Now, if that doesn’t prick up investor ears or yank a few...

Zabalafin Hydrogel: Promise in Treating Atopic Dermatitis

Pioneering a New Path in Dermatology Treatment In the world of dermatology, finding a topical solution that tackles the full spectrum of atopic dermatitis (AD) is as rare as hens' teeth. But here's a twist—in a recent research paper gracing the Journal of Drugs in Dermatology, Alphyn Biologics sheds light on their unique contender, Zabalafin Hydrogel. This ain't your...